Atlas Trials

Efficacy and Safety of Microwave Ablation Combined With Camrelizumab and Chemotherapy in Patients With Advanced Non-small Cell Lung Cancer: a Multicenter, Open, Prospective Study

Clinical trial NCT05532527 · UNKNOWN

Trial details

NCT number
NCT05532527
Sponsor
Henan Provincial People's Hospital
Status
UNKNOWN
Phase
Not Applicable
Study type
INTERVENTIONAL
Nsclc
Start date
2022-09-20
Primary completion
2023-09-20
Enrollment
35

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.